These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 11205155)

  • 21. The role of iron in senescence of dopaminergic neurons in Parkinson's disease.
    Youdim MB; Riederer P
    J Neural Transm Suppl; 1993; 40():57-67. PubMed ID: 8294901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controversies about iron in parkinsonian and control substantia nigra.
    Gałazka-Friedman J; Friedman A
    Acta Neurobiol Exp (Wars); 1997; 57(3):217-25. PubMed ID: 9407708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain Iron Metabolism Dysfunction in Parkinson's Disease.
    Jiang H; Wang J; Rogers J; Xie J
    Mol Neurobiol; 2017 May; 54(4):3078-3101. PubMed ID: 27039308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases.
    Dusek P; Roos PM; Litwin T; Schneider SA; Flaten TP; Aaseth J
    J Trace Elem Med Biol; 2015; 31():193-203. PubMed ID: 24954801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease.
    Youdim MB; Lavie L
    Life Sci; 1994; 55(25-26):2077-82. PubMed ID: 7527888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.
    Zecca L; Stroppolo A; Gatti A; Tampellini D; Toscani M; Gallorini M; Giaveri G; Arosio P; Santambrogio P; Fariello RG; Karatekin E; Kleinman MH; Turro N; Hornykiewicz O; Zucca FA
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9843-8. PubMed ID: 15210960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.
    Riederer P; Monoranu C; Strobel S; Iordache T; Sian-Hülsmann J
    J Neural Transm (Vienna); 2021 Oct; 128(10):1577-1598. PubMed ID: 34636961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain iron pathways and their relevance to Parkinson's disease.
    Berg D; Gerlach M; Youdim MB; Double KL; Zecca L; Riederer P; Becker G
    J Neurochem; 2001 Oct; 79(2):225-36. PubMed ID: 11677250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.
    Zhang J; Perry G; Smith MA; Robertson D; Olson SJ; Graham DG; Montine TJ
    Am J Pathol; 1999 May; 154(5):1423-9. PubMed ID: 10329595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
    Zecca L; Berg D; Arzberger T; Ruprecht P; Rausch WD; Musicco M; Tampellini D; Riederer P; Gerlach M; Becker G
    Mov Disord; 2005 Oct; 20(10):1278-85. PubMed ID: 15986424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
    Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.
    Zucca FA; Segura-Aguilar J; Ferrari E; Muñoz P; Paris I; Sulzer D; Sarna T; Casella L; Zecca L
    Prog Neurobiol; 2017 Aug; 155():96-119. PubMed ID: 26455458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
    Berg D
    J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
    Thompson K; Menzies S; Muckenthaler M; Torti FM; Wood T; Torti SV; Hentze MW; Beard J; Connor J
    J Neurosci Res; 2003 Jan; 71(1):46-63. PubMed ID: 12478613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease.
    Gerlach M; Riederer P; Double KL
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S185-8. PubMed ID: 18585086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.